Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Zuckerman Investment Group LLC

Zuckerman Investment Group LLC reduced its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 68.2% in the 4th quarter, Holdings Channel.com reports. The firm owned 118,860 shares of the company’s stock after selling 254,920 shares during the quarter. Zuckerman Investment Group LLC’s holdings in Henry Schein were worth $8,225,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Lyrical Asset Management LP acquired a new position in Henry Schein during the 4th quarter worth approximately $126,655,000. Norges Bank acquired a new stake in Henry Schein during the fourth quarter worth approximately $103,301,000. National Bank of Canada FI boosted its holdings in shares of Henry Schein by 102.4% in the 4th quarter. National Bank of Canada FI now owns 1,084,511 shares of the company’s stock valued at $75,048,000 after purchasing an additional 548,561 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of Henry Schein during the 4th quarter valued at $34,720,000. Finally, Clarkston Capital Partners LLC lifted its position in Henry Schein by 24.8% during the 4th quarter. Clarkston Capital Partners LLC now owns 1,744,225 shares of the company’s stock worth $120,700,000 after acquiring an additional 346,420 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Stock Performance

Shares of NASDAQ:HSIC opened at $66.16 on Thursday. The business has a 50-day moving average price of $72.55 and a two-hundred day moving average price of $72.32. The stock has a market capitalization of $8.22 billion, a P/E ratio of 27.23, a P/E/G ratio of 2.13 and a beta of 0.84. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter in the previous year, the business posted $0.66 earnings per share. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. Equities analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Wall Street Analyst Weigh In

HSIC has been the topic of several recent analyst reports. StockNews.com raised shares of Henry Schein from a “hold” rating to a “buy” rating in a report on Wednesday. UBS Group reduced their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Jefferies Financial Group raised their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and upped their price target for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. Finally, Wells Fargo & Company started coverage on shares of Henry Schein in a research note on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price for the company. Five investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $81.10.

Insider Buying and Selling

In related news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the business’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares of the company’s stock, valued at $1,762,147.20. The trade was a 9.50 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.